News
Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc ...
Spectral AI, Inc. Q1 Overview. Research & Development Revenue of $6.7 Million. Improved Capital Structure Reflected in Cash of $14.1 Million. Continued work on planned De Novo submission to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback